Drug Profile
TEI SARM2
Alternative Names: TEI-SARM2Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Teijin Pharma
- Class
- Mechanism of Action Androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Musculoskeletal disorders
Most Recent Events
- 03 Oct 2023 Discontinued - Preclinical for Musculoskeletal disorders in Japan (PO) (Teijin Pharma pipeline, October 2023)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Musculoskeletal-disorders in Japan (PO)